buy paxil online obstetrics and gynecology doctor buy cymbalta online circulation cymbalta site management buy prozac online relative value unit antidepressant buy coumadin online bandages online buy celexa online menstrual disorders sale shop buy abilify online compression spot

HealthMoney

Does Medicare Part D track record make Ryan’s case for privatization?

Posted on 24 May 2011

By Mark Miller

Can privatization cure what ails Medicare?

Rep. Paul Ryan (R-Wisconsin) thinks so. The House Budget Chairman points often to the Medicare Part D prescription drug program as proof that competition among private insurers has saved billions for taxpayers. It’s a key line of defense in the Republicans’ controversial plan to replace traditional Medicare with a privatized voucher program.

It’s true that government spending on Part D is running far below projections made by the Congressional Budget Office (CBO) when the drug plan was first created. But it’s not clear that the lower spending results from Part D’s privatization features. The lower spending actually reflects slower spending on prescription drugs throughout the health system and lower-than-expected enrollment in Part D.

Learn more in my column this week at Reuters Wealth.

Tags |

Comments are closed.

The Hard Times Guide to Retirement and Security - Order Now!
Privacy Policy